These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9279687)

  • 1. Experimental approaches for the treatment of murine B16 melanomas of various sizes. I: Local injection of ethanol with a combination of interleukin-2 or microwaval hyperthermia for B16 melanomas with a size of less than 7 mm in diameter.
    Nakayama J; Kokuba H; Kobayashi J; Yoshida Y; Hori Y
    J Dermatol Sci; 1997 Aug; 15(2):75-81. PubMed ID: 9279687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental approaches for the treatment of murine B16 melanomas of various sizes. II: Injection of ethanol with combinations of beta-interferon and microwaval hyperthermia for B16 melanomas with a size of greater than 10 mm in diameter.
    Nakayama J; Kokuba H; Kobayashi J; Yoshida Y; Hori Y
    J Dermatol Sci; 1997 Aug; 15(2):82-8. PubMed ID: 9279688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ detection of immunocompetent cells in murine B16 melanoma locally treated with interleukin-2 or microwaval hyperthermia.
    Nakayama J; Urabe A; Terao H; Taniguchi S; Hori Y
    Pigment Cell Res; 1993 Mar; 6(2):111-6. PubMed ID: 8100634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of murine melanoma growth with a combination of microwave hyperthermia and local injection of interleukin 2.
    Nakayama J; Urabe A; Toyofuku K; Taniguchi S; Hori Y
    Br J Dermatol; 1994 Jun; 130(6):717-24. PubMed ID: 8011496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined therapeutic modality with hyperthermia and locally administered rIFN-beta inhibited the growth of B16 melanoma in association with the modulation of cellular infiltrates.
    Nakayama J; Toyofuku K; Urabe A; Taniguchi S; Hori Y
    J Dermatol Sci; 1993 Dec; 6(3):240-6. PubMed ID: 8136321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different sensitivities of the murine melanomas BL-6 and BL-6-beta m to local injections of interleukin-2 (IL-2). Analysis of gangliosides after the treatment.
    Nakayama J; Tsuchida T; Toyofuku K; Shimokawa-Kuroki R; Taniguchi S; Hori Y
    Melanoma Res; 1994 Oct; 4(5):297-302. PubMed ID: 7858413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid destruction of murine and human melanomas by local injection of absolute ethanol: augmentation of the anti-proliferative effects with a combination of biological response modifiers.
    Nakayama J; Toyofuku K; Kokuba H; Hori Y
    J Dermatol; 1996 Mar; 23(3):156-64. PubMed ID: 8935625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of ionising radiation with hyperthermia increases the immunogenic potential of B16-F10 melanoma cells in vitro and in vivo.
    Werthmöller N; Frey B; Rückert M; Lotter M; Fietkau R; Gaipl US
    Int J Hyperthermia; 2016; 32(1):23-30. PubMed ID: 26754406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles.
    Ito A; Yamaguchi M; Okamoto N; Sanematsu Y; Kawabe Y; Wakamatsu K; Ito S; Honda H; Kobayashi T; Nakayama E; Tamura Y; Okura M; Yamashita T; Jimbow K; Kamihira M
    Nanomedicine (Lond); 2013 Jun; 8(6):891-902. PubMed ID: 23066648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B; Shen RN; Wang WX; Broxmeyer HE; Lu L
    Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cell- and immuno-biological properties of murine B16-F1 and F10 melanomas: oncogene c-fos expression, sensitivity to LAK cells and/or IL-2, and components of gangliosides.
    Nakayama J; Urabe K; Tsuchida T; Urabe A; Terao H; Taniguchi S; Hori Y
    J Dermatol; 1995 Aug; 22(8):549-59. PubMed ID: 7560451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined local hyperthermia and immunotherapy treatment of an experimental subcutaneous murine melanoma.
    Geehan DM; Fabian DF; Lefor AT
    J Surg Oncol; 1995 May; 59(1):35-9. PubMed ID: 7745975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
    Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
    Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with interleukin-2/interferon-gamma double cytokine-secreting allogeneic fibroblasts prolongs the survival of mice with melanoma.
    Kim TS; Xu WS; Sun T; Cohen EP
    Melanoma Res; 1995 Aug; 5(4):217-27. PubMed ID: 7496156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-18 and the costimulatory molecule B7-1 have a synergistic anti-tumor effect on murine melanoma; implication of combined immunotherapy for poorly immunogenic malignancy.
    Cho D; Kim TG; Lee W; Hwang YI; Cho HI; Han H; Kwon O; Kim D; Park H; Houh D
    J Invest Dermatol; 2000 May; 114(5):928-34. PubMed ID: 10771473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of lymph node and pulmonary metastases after local irradiation and hyperthermia of footpad melanomas.
    Nathanson SD; Nelson L; Anaya P; Havstad S; Hetzel FW
    Clin Exp Metastasis; 1991; 9(4):377-92. PubMed ID: 1868628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex.
    Asada H; Kishida T; Hirai H; Satoh E; Ohashi S; Takeuchi M; Kubo T; Kita M; Iwakura Y; Imanishi J; Mazda O
    Mol Ther; 2002 May; 5(5 Pt 1):609-16. PubMed ID: 11991752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of radiotherapy by hyperthermia-regulated gene therapy.
    Lohr F; Hu K; Huang Q; Zhang L; Samulski TV; Dewhirst MW; Li CY
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1513-8. PubMed ID: 11121657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice.
    Lu L; Xiao M; Wu B; Wang WX; Yan WR; Broxmeyer HE; Shen RN
    Int J Hematol; 1993 Oct; 58(3):139-52. PubMed ID: 8148492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.